Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +32.72%
#3 Fabric Protocol Fabric Protocol +23.80%
#4 Cysic Cysic +20.00%
#5 Nockchain Nockchain +19.55%
#6 Bedrock Bedrock +17.90%
#7 Epic Chain Epic Chain +12.10%
#8 Perle Perle +11.39%
#9 FOLKS FOLKS +8.38%
#10 The Black Bull The Black Bull +8.04%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Clasificación en acciones #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Precio por acción
$0.1
Última sincronización: 2024-06-18
Capitalización bursátil
$1.31M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Pascal Biosciences Inc. (PSCBF)

Categoría

Healthcare
Ratio P/S de Pascal Biosciences Inc. (PSCBF)
Ratio P/S al August 2026 TTM: 8.69
Según los informes financieros más recientes y el precio de las acciones de Pascal Biosciences Inc., el ratio P/S actual (TTM) es 8.69. Al final de 2022, el ratio P/S era 0.00.
Historial del ratio P/S de Pascal Biosciences Inc. desde 2019 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 8.69 264.97%
2023 2.38 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 13.75%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 16.61%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -42.68%
BE